|
|
||||||||
|

Figure 2. T1-weighted MRI after gadolinium administration with several enhancing lesions on October 10, 1998 (A) and a reduction in the number of enhancing lesions by December 16, 1998 (B).
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |